The Scheme is fully funded and subject to limited customary conditions, including various regulatory approvals, approval by Mayne Pharma shareholders at the Scheme meeting, with a Scheme booklet and an independent expert’s report to be provided to Mayne Pharma shareholders, and Court approval. Certainly
100% voting no...
Mayne Pharma Chair, Frank Condella, said: “We are pleased that Cosette has recognised significant value in Mayne Pharma, particularly in our women’s health and dermatology businesses, and the offer provides shareholders with the opportunity to receive cash value at a significant premium. The Board believes that the proposed transaction is in line with the Board’s priority to deliver value to our shareholders, and also provides significant benefits for our broader stakeholders.”
what significant benefits? a massive loss ? what broader share holders? Himself...? Lunacy.
MYX Price at posting:
$7.21 Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)